tebonin Report issue

Botanical Experimental
AACT MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

Alternative names

egb761 | egb 761 | egb-761 | gbe 761 | gbe-761 | gbe 761 onc | gingko biloba extract | ginkgo biloba extract | ginkgo biloba extract 761 | ginkgo leaf extract | rokan | tanakan | tebofortran | tebokan | tebonin

Organizations (4)

Research & Development (4)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (11)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (11)


 

Alzheimer Disease (Phase 2)

Brain Neoplasms (Phase 2)

Cognitive Dysfunction (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Friedreich Ataxia (Phase 2)

Memory Disorders (Phase 4)

Multiple Sclerosis, Relapsing-Remitting (Phase 3)

Schizophrenia (Phase 3)

Stroke (Phase 3)

Tardive Dyskinesia (Phase 3)

Urological Manifestations (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial Organizations: 4

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue